CalciMedica, Inc. (CALC) stock
CALCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.17−0.05 (-4.10%)
Close on Nov 18, 2026Market cap $39.95MP/E –Yield –
CalciMedica free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
CalciMedica's free cash flow for the twelve months ending Jun 30, 2026 was -$19.12M. For fiscal 2025 it was -$21.21M. The highest annual figure on record is -$11.76M in fiscal 2022.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$21.21M | – |
| FY2024 | Dec 31, 2024 | -$21.15M | – |
| FY2023 | Dec 31, 2023 | -$25.81M | – |
| FY2022 | Dec 31, 2022 | -$11.76M | – |
| FY2021 | Dec 31, 2021 | -$31.99M | – |
| FY2020 | Dec 31, 2020 | -$33.09M | – |
| FY2019 | Dec 31, 2019 | -$31.82M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.62M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.86M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.86M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.79M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.68M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.89M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.97M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.67M | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.79M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.72M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.61M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.57M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.22M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.63M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.96M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.68M | – |
| Q2 FY2021 | Jun 30, 2021 | -$7.95M | – |
| Q1 FY2021 | Mar 31, 2021 | -$9.40M | – |
| Q4 FY2020 | Dec 31, 2020 | -$10.60M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.40M | – |
| Q2 FY2020 | Jun 30, 2020 | -$6.23M | – |
| Q1 FY2020 | Mar 31, 2020 | -$10.86M | – |
| Q4 FY2019 | Dec 31, 2019 | -$10.02M | – |
See a number that looks wrong?